Meningitis is one of the deadly diseases that occurs when the tissues surrounding the brain and spinal cord is inflammed. The disease is usually fatal often requiring immediate medical care. Globally, it is estimated that over 1.2 million cases of bacterial meningitis occur worldwide each year. The five regions of Northern Ghana (Northern, North East, Savanna, Upper East and Upper West), some parts of the Oti and Bono East regions of Ghana fall within the African meningitis belt and are mostly affected.
In 1996/97 outbreak, Ghana recorded more than 17,000 meningitis cases with 1,200 (7.1%) deaths. In 2016, another outbreak was recorded affecting 59 districts in nine regions resulting in 2,184 confirmed cases with 93 deaths. In 2020, 40 individuals reportedly died in the Upper West region as a result of meningitis. Early detection of meningitis is an essential requirement in survival and well-being of patient.
In order to improve the capacity of laboratory scientists in detection of meningitis pathogens, the Centre for Health System Strengthening (CfHSS) in collaboration with the Centers for Disease Control and Prevention, US CDC, and the Ghana Health Service (GHS), organized a comprehensive training in the use of rapid tests for pathogen detection. This training program represents a significant step forward in enhancing healthcare capabilities in the region.
Led by esteemed facilitators, the training focused on utilizing rapid diagnostic tests such as LAT (Latex Agglutination Test) kits (Pastorex and Wellcogen), Negative staining (Nigrosin and Indian ink), and Gram-staining techniques. Participants delved into comprehensive sessions covering the identification of meningitis types, early diagnosis significance, and epidemiological insights crucial for effective disease management.
Through hands-on practical sessions and engaging case-study activities, participants developed know-how in performing accurate and reliable diagnostic tests, ensuring timely detection of meningitis pathogens. The program emphasized stringent quality control measures and adherence to safety guidelines, fostering a culture of precision and reliability in laboratory practices.
Furthermore, the training fostered collaboration and knowledge exchange among participants, paving the way for enhanced healthcare delivery and disease surveillance efforts in the Northern regions. Participants were not only awarded certificates and Gram-Stain sets, but also gained valuable Continuing Professional Development (CPD) points, affirming their commitment to ongoing professional growth and excellence.
This milestone achievement buttresses our unwavering commitment to advancing public health initiatives and building resilient healthcare systems in underserved regions. As we celebrate this success, we look forward to continued collaboration and future endeavors aimed at improving healthcare outcomes for all.
